Advertisement

India

Updated on: Sunday, August 01, 2021, 12:50 AM IST

India, UK to conduct clinical trials on 'Ashwagandha' for Covid recovery

Advertisement

New Delhi

The Ayush ministry's All India Institute of Ayurveda in collaboration with the United Kingdom's London School of Hygiene and Tropical Medicine will conduct a study on 'Ashwagandha' for promoting recovery from Covid in a boost to the traditional Indian medicine system.

Both the institutions signed a Memorandum of Understanding to conduct the clinical trials of Ashwagandha on 2,000 people in three UK cities -- Leicester, Birmingham and London (Southall and Wembley), said the ministry in a statement.

Ashwagandha (Withania Somnifera), commonly known as 'Indian winter cherry', is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger.

It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in Covid, which is a multi-system disease with no evidence of its effective treatment or management.

The successful completion of the trial can be a major breakthrough and give scientific validity to India's traditional medicinal system. While there have been several studies on Ashwagandha to understand its benefits in various ailments, this is the first time the Ministry has collaborated with a foreign institution to investigate its efficacy on Covid patients.

AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator - International Projects, said that the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Published on: Sunday, August 01, 2021, 12:50 AM IST
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement